Ronald E Osman Irrevocable Trust III 13D and 13G filings for Inhibitor Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-17 6:56 pm Purchase | 2023-05-05 | 13G | Inhibitor Therapeutics, Inc. INTI | Ronald E Osman Irrevocable Trust III | 25,989,985 15.120% | 25,989,985 (New Position) | Filing |